WST - WEST PHARMACEUTICAL SERVICES INC

QQQ $ 629.92 $ 0.00 (0 %)

DIA $ 478.27 $ 0.00 (0 %)

SPY $ 686.66 $ 0.00 (0 %)

TLT $ 91.82 $ 0.00 (0 %)

GLD $ 360.83 $ 0.00 (0 %)

Previous Close

$ 287.22

Open

$ 299.99

Bid

$ 287.24 x 6

Ask

$ 293.00 x 3

Day's Range

-- - --

52 Week Range

$ 187.09 - $ 348.05

Volume

1,067,880

Average Volume

Market Cap

20.66B

Beta (5Y Monthly)

$ 1.05

PE Ratio (TTM)

$ 42.02

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	10-23-2025	09-30-2025	10-Q
2	07-24-2025	06-30-2025	10-Q
3	04-24-2025	03-31-2025	10-Q
4	02-18-2025	12-31-2024	10-K
5	10-24-2024	09-30-2024	10-Q
6	07-25-2024	06-30-2024	10-Q
7	04-25-2024	03-31-2024	10-Q
8	02-20-2024	12-31-2023	10-K
9	10-26-2023	09-30-2023	10-Q
10	07-27-2023	06-30-2023	10-Q
11	04-27-2023	03-31-2023	10-Q
12	02-21-2023	12-31-2022	10-K
13	10-27-2022	09-30-2022	10-Q
14	07-28-2022	06-30-2022	10-Q
15	04-28-2022	03-31-2022	10-Q
16	02-22-2022	12-31-2021	10-K
17	10-28-2021	09-30-2021	10-Q
18	07-30-2021	06-30-2021	10-Q
19	04-30-2021	03-31-2021	10-Q
20	02-23-2021	12-31-2020	10-K
21	10-23-2020	09-30-2020	10-Q
22	07-24-2020	06-30-2020	10-Q
23	04-24-2020	03-31-2020	10-Q
24	02-24-2020	12-31-2019	10-K
25	10-29-2019	09-30-2019	10-Q
26	07-29-2019	06-30-2019	10-Q
27	05-08-2019	03-31-2019	10-Q
28	02-28-2019	12-31-2018	10-K
29	10-30-2018	09-30-2018	10-Q
30	07-31-2018	06-30-2018	10-Q
31	05-08-2018	03-31-2018	10-Q
32	02-26-2018	12-31-2017	10-K
33	10-31-2017	09-30-2017	10-Q
34	08-01-2017	06-30-2017	10-Q
35	05-05-2017	03-31-2017	10-Q
36	02-28-2017	12-31-2016	10-K
37	10-31-2016	09-30-2016	10-Q
38	08-01-2016	06-30-2016	10-Q
39	05-06-2016	03-31-2016	10-Q
40	02-26-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Barclays Maintains Equal-Weight on West Ph...
10/27/2025 16:25:26

Barclays analyst Luke Sergott maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight and raises the price target...

1. West Pharmaceutical Unveils New Prefill...
10/27/2025 10:10:20

West Pharmaceutical Services, Inc. (NYSE:WST), a global leader in innovative solutions for injectable drug administration, tod...

Demystifying West Pharmaceutical Servs: In...
10/24/2025 18:01:34

UBS Maintains Buy on West Pharmaceutical S...
10/24/2025 15:05:44

UBS analyst John Sourbeer maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $320 to...

Keybanc Maintains Overweight on West Pharm...
10/24/2025 12:33:41

Keybanc analyst Paul Knight maintains West Pharmaceutical Servs (NYSE:WST) with a Overweight and raises the price target fro...

Evercore ISI Group Maintains Outperform on...
10/23/2025 17:54:02

Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs (NYSE:WST) with a Outperform and raises the ...

oil-stocks-rally-on-trumps-russia-sanctions-whats-moving-markets-thursday

Oil Stocks Rally On Trump's Russia Sanctio...
10/23/2025 16:55:59

Energy markets dominated headlines Thursday as a fresh wave of U.S. sanctions targeting Russia's oil giants sparked a sharp...

west-pharma-soars-after-q3-beat-lifts-outlook-on-glp-1-demand

West Pharma Soars After Q3 Beat, Lifts Out...
10/23/2025 16:16:29

West Pharmaceutical posts Q3 earnings of $1.96 per share and raises 2025 guidance, driven by GLP-1 demand and strong HVP compon...

las-vegas-sands-posts-upbeat-q3-results-joins-garrett-motion-lendingclub-dow-hexcel-and-other-big-stocks-moving-higher-on-thursday

Las Vegas Sands Posts Upbeat Q3 Results, J...
10/23/2025 14:34:47

West Pharmaceutical Servs Raises FY2025 Ad...
10/23/2025 10:02:06

West Pharmaceutical Servs (NYSE:WST) raises FY2025 Adj EPS guidance from $6.65-$6.85 to $7.06-$7.11 vs $6.77 analyst estimate. ...

West Pharmaceutical Servs Raises FY2025 GA...
10/23/2025 10:01:29

West Pharmaceutical Servs (NYSE:WST) raises FY2025 GAAP EPS guidance from $6.36-$6.56 to $6.75-$6.80 vs $6.53 analyst estimate..

West Pharmaceutical Servs Q3 Adj. EPS $1.9...
10/23/2025 10:00:55

West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $1.96 per share which beat the analyst consensus estimate o...

Earnings Scheduled For October 23, 2025
10/23/2025 08:32:24

West Pharmaceutical Servs's Earnings Outlook
10/22/2025 16:02:08

Barclays Maintains Equal-Weight on West Ph...
10/02/2025 15:08:24

Barclays analyst Luke Sergott maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight and raises the price target...

Deep Dive Into West Pharmaceutical Servs S...
10/02/2025 14:01:02

Looking Into West Pharmaceutical Servs's R...
09/25/2025 18:00:56

West Pharmaceutical Servs's (NYSE: WST) short interest as a percent of float has risen 9.25% since its last report. Accordi...

Rothschild & Co Initiates Coverage On West...
09/15/2025 13:42:34

Rothschild & Co analyst Jamie Clark initiates coverage on West Pharmaceutical Servs (NYSE:WST) with a Buy rating and ann...

thermo-fisher-baker-hughes-and-iqvia-holdings-are-among-top-10-large-cap-gainers-last-week-july-21-july-25-are-the-others-in-your-portfolio

Thermo Fisher, Baker Hughes And IQVIA Hold...
07/27/2025 14:16:06

Medpace, ICON, and West Pharma led last week's large-cap rally, driven by strong earnings beats and upgraded guidance.

UBS Maintains Buy on West Pharmaceutical S...
07/25/2025 16:06:11

UBS analyst John Sourbeer maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $285 to...